Government Funded Innovations in Phytopharmaceuticals Exploring the Medicinal Potential of Costus Speciosus

Author(s)	Dr. Savita Mohindra, Dr. Malika Pal, Dr. Mukta Shrivastava
Country	India
Abstract	Abstract The plant-based therapeutics has positioned phytopharmaceuticals at the forefront of modern drug discovery. Costus speciosus, commonly known as crepe ginger, is a perennial herb extensively utilized in traditional medicine systems like Ayurveda and Unani. Recognized for its diverse pharmacological properties—including antidiabetic, anti-inflammatory, antimicrobial, and antioxidant effects—this plant has garnered significant scientific interest. This paper delves into government-funded initiatives in India aimed at exploring and harnessing the medicinal potential of Costus speciosus. It encompasses advanced phytochemical analyses, molecular characterizations, and preclinical trials supported by national research councils. These endeavors align with objectives of sustainable healthcare, integration of indigenous knowledge, and economic upliftment through plant-based drug development. The study discusses current advancements, funding mechanisms, and the translational potential of Costus speciosus within the broader framework of phytopharmaceutical innovation in India.
Published In	Volume 7, Issue 3, May-June 2025
Published On	2025-06-05
DOI	https://doi.org/10.36948/ijfmr.2025.v07i03.46593
Short DOI	https://doi.org/g9pzr9

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research